believ captiv pbm stigma
major accret eventu level roll-off get
investor may disappoint use stockpil cash under-
lever balanc sheet post merger process buy larg independ pbm
instead anoth dedic government market either medicar medicaid
market share peer sell-off ci share
back esrx pbm transact provid mid-teen sustain accret
ex-anthem littl surpris sens one primari concern around
transact whether express script could lose custom contract post-
merger compani market primari independ pbm
marketplac past five year independ esrx disappear
howev discuss detail pg report believ
may concern due pbm industri evolut captiv pbm stigma like gone
also updat barclay pbm market model figur page note
accret investor concern follow note overnight regard
hypothet cigna/express script transact compani formal announc
deal bn full financi detail manag indic esrx accret ci
mid-teen rang year impli ep exclud
expect compon rais ep guidanc
figur calcul new term suggest ep accret
interestingli pro-forma ep would increas
stay rel flat within ci
project rang risk relat potenti custom attrit
esrx pbm lack independ trim ep estim ci slightli
reflect buy-back activ rest esrx deal
pend pt base price-to-earnings ep estim
ci quarterli annual ep usd
consensu number thomson reuter
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
return equiti ttm
link barclay live interact chart
overweight price target
base price-to-earnings ep street
compani continu leverag
strength control medic cost embark
capit deploy follow conclus
upsid case base
price-to-earnings higher ep compani abl
control medic cost even greater pace
expect
downsid case base lower
price-to-earnings lower ep compani less abl
sustain industri lead medic cost trend vs
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
invest commun fulli awar deal term propos
merger express script accur calcul potenti
accret new total consider bn esrx includ bn
new debt assum interest rate bn assum esrx net debt also
interest rate bn new ci equiti issuanc use bn avail cash
new term suggest ep accret
interestingli pro-forma ep would increas stay rel
flat also assum approxim mln
addit share account foregon buyback buy-back activ
resum help investor determin amount accret deriv
legaci script oper vs soon-to-be-lost custom
contract show breakdown figur page report
 bn ress script bn acquisit esrxactualactualactualprojectedprojectedprojectedprojectedtot esrx adjust esrx oper ebitda increment interest interest assum esrx net foregon interest ress script increment pre-tax incom stand-alone pre-tax net compani pre-tax net combin compani combin compani net stand-alone combin compani ep accret ci share fulli dilut share foregon share buyback issu compani fulli dilut barclay
strateg intersect pharmaci manag reunit
percept pbm marketplac pbm asset
own oper manag care scale effici
sophist expertis independ pbm abil control pharmaci cost
result independ pbm continu wit market share gain expens
captiv pbm own manag care compani stigma grew among
commerci custom base pbm market carv pharmaci benefit
independ pbm like lead better pharmaci cost trend carv
health benefit administr ultim led market capitul seri
manag care compani decid throw proverbi towel sell either part
pbm asset independ pbm took place roughli year ago larg
mco anthem aetna smaller health plan announc
transact independ pbm wave pbm outsourc
smaller transact occur preced year well involv mco either exit pbm
ownership and/or outsourc independ
total adjust script script medco rx part n/an/an/an/aprim ingeniorx total adjust script share total adjust scriptscv script medco rx part adjust script changecv script medco rx part -- -- adjust script data start adjust retail rx prior period adjust mail rx equival note individu compani forward project exclud due restrict barclay
unitedhealth group almost single-handedli end stigma
howev grow sophist manag care compani greater
need/desir take hands-on approach control medic cost
buck trend announc around intent bring in-
hous outsourc commerci pbm servic goal build market-
lead pbm asset could success compet busi carved-in
carved-out basi base unh pbm market share
consensu view success achiev pbm goal
success endeavor past five year gone long way toward essenti
elimin aforement stigma marketplac relat captiv pbm
seemingli trigger wave strateg decis pbm manag
market describ greater detail
usher new world order manag pharmaci
discuss section report manag refer
optumrx pbm frequent util real-tim consum touchpoint
entir healthcar system use frequent interact creat whole pictur
member guid peopl clinic appropri medic simultan
provid greater transpar pharmaci cost context overal health
care cost strategi believ optumrx gain pbm market share
 past coupl year market data analyt capabl
connect pharmaci care overal patient care
decemb enter agreement acquir aetna total
transact price bn merger-rel confer call decemb
manag aetna state transact creat lead health
care platform revolution consum healthcar experi healthcar
stakehold state combin compani deliv high-touch connect
consum improv qualiti life drive effici lower cost
care manag went state compani share vision critic role
pharmaci care play deliv qualiti outcom lower overal healthcar cost
togeth compani said plan build entir new healthcar concept
base principl make care easier use afford aetna
consum health engag model cvss reach scale compani plan
toutil combin clinic expertis enhanc valu tighter integr
pharmaci medic benefit manag manag said combin compani
use high-touch connect becom front door health care consum
manag state combin medicar advantag medicar part
asset two compani new merg entiti abl improv qualiti
metric becom competit fast-grow medicar market
data analyt also variabl cvs/aetna merger accord
relat new compani plan marri physic digit touch point
broader use data analyt inform health care decision-mak integr data
across new enterpris asset use predict analyt
compani said creat target interact patient drive adher
manag see healthcar marketplac evolv value-bas system
import medicar commerci compani plan becom
leader drive adopt value-bas model promot lower-cost site
care ceo aetna particular state confer call transact
potenti medicar medicaid member provid high-touch
interact need navig complex health care system
believ could differ type benefit plan group truli put
financ background reward consum proactiv
manag put number behind manag care/pharmaci save
accord manag combin data analyt enabl new
compani use pharmaci care drive overal health care cost prescript
cost manag demonstr integr medic pharmaci
result increas case manag engag pmpm per
member per month reduct total medic cost averag member chronic
condit save approach pmpm end day manag
note everi basi point aetna reduc medic cost trend result
nearli mn addit underwrit margin aetna custom
implic aetna financi perform well accord compani cost
improv allow aetna reinvest health member drive increas
loyalti retent improv qualiti afford product servic
expand new geographi serv addit member profit top-lin
growth compani expect mn year synergi combin pbm
medicar part oper reduc medic cost shift care lower-cost
set well typic redund corpor function streamlin
also grab back rein pbm servic
underscor view captiv pbm stigma marketplac quit
posit strateg decis creat pbm call ingeniorx start
late simultan conclus pbm outsourc
agreement express script announc strategi
addit serv exist medic member roughli mn prescript
annual new ingeniorx pbm also compet open pbm marketplac
carve-out opportun manag emphas ingeniorx pbm
go market compet free-stand pbm fortun
business/larg local busi core market also discuss
similar compon cvs/aet relat pbm strategi
discuss greater detail
ingeniorx oper end-to-end solut member distinct
competit advantag achiev leverag clinic expertis suit well-b
solut local market focu deep provid relationship align
incent model focus manag overal cost care compon
benefit approach shown figur figur
success whole health approach
compliant
medic
note analysi intern data
also look creat solut ensur oper excel relat
partnership health ingeniorx retain control
key pharmaci servic leverag best-in-class oper perform
scale retail presenc clear ingeniorx firmli control
clinic formulari strategi develop member employ experi
account manag sale market retail network strategi
relat price term exist express script well
market rate expect bn annual pharmaci save ingenio
rx run beyond save show primarili
medic cost line
never pull trigger full pbm outsourc option
juli announc pbm partnership agreement independ pbm
catamaran own new pbm agreement minimum
involv shift plain-vanilla prescript claim process function catamaran
initi compon partnership beyond option within
contract term potenti outsourc addit pbm servic catamaran time
howev understand ultim never realli pull trigger
major addit outsourc option past five year thu still
essenti fully-funct pbm in-hous client interfac servic
perspect strateg import emphas analyst meet
describ detail
critic keep pbm in-hous relat value-bas strategi
quit time view pharmaci portion busi critic
effect creat better servic experi clinic outcom individu
increasingli better opportun partner effect health care
profession enabl creat better valu patient evolut toward
value-bas care vbc arrang relat taken step forward
multipl value-bas care program alreadi specialti pharmaci space within
pbm oper orient toward health care profession side
equat point touch/interact individu get pharmaceut
experi integr practition gener much power outcom
manag view number one gap care america still tie
pharmaceut wrong drug wrong dose wrong durat drug therapi
conclus seem share strateg view mani diversifi
mco relat pbm oper
time announc deal catamaran disclos
approxim mn annual adjust prescript rx claim includ
healthspr book busi acquir year prior relat
cigna pbm integr within overal medic benefit book busi compani
rank current pbm penetr mid-high carved-in penetr
exist book increas time pharmaci relationship outpac
growth medic relationship estim may closer mln
adjust rx claim pbm today also adjust retail well
express script annual anthem statist adjust ep transit clientscoventri catamaran rx ep contribut transit clientsadjust pbmadjust esrx ep esrx price-to-earnings base current share esrx ratesanthemanthem adjust ep contribut transit clientscoventri catamaran rx contribut transit clientsadjust pbmadjust pbm ep barclay
steve valiquett herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
